Anqiang Wang
Overview
Explore the profile of Anqiang Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1681
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li J, Chen J, Sun X, Yang H, Sun K, Liu C, et al.
Sci Bull (Beijing)
. 2024 Apr;
69(19):2987-2992.
PMID: 38664094
No abstract available.
2.
Zhang Y, Zhang H, Yan Y, Ji K, Jia Z, Yang H, et al.
Chin J Cancer Res
. 2024 Jan;
35(6):645-659.
PMID: 38204447
Objective: The aim of this study was to prospectively compare double-tract reconstruction (DTR) and esophagogastrostomy (EG) after proximal gastrectomy (PG) regarding the incidence of reflux esophagitis, quality of life (QOL),...
3.
Yang X, Wu Y, Wang A, Ma X, Zhou K, Ji K, et al.
J Pathol Clin Res
. 2023 Nov;
10(1):e343.
PMID: 37974386
Hepatoid adenocarcinoma of stomach (HAS) is a special subtype of gastric cancer with poor prognosis. Immunohistochemical analysis could provide important clues for the treatment of HAS. A total of 159...
4.
Wei J, Ji K, Zhang Y, Zhang J, Wu X, Ji X, et al.
Cell Oncol (Dordr)
. 2023 Nov;
47(2):677-693.
PMID: 37943484
Purpose: Preoperative neoadjuvant chemotherapy may not improve the prognosis of patients with hepatoid adenocarcinoma of the stomach (HAS), a rare pathological type of gastric cancer. Thus, the study aimed at...
5.
Wang K, Zhang H, Wang C, Qiu F, Wang A
Rev Esp Enferm Dig
. 2023 Sep;
115(10):592-593.
PMID: 37732345
GAVE is a relatively rare acquired vascular disease. The most common treatment for GAVE is endoscopic therapy. Argon plasma coagulation（APC） is usually the first-line choice for endoscopic GAVE treatment, but...
6.
Zhou K, Wang A, Bu Z
Gastroenterology
. 2023 Jun;
165(6):1582-1583.
PMID: 37269966
No abstract available.
7.
Sun C, Wang A, Zhou Y, Chen P, Wang X, Huang J, et al.
Nat Commun
. 2023 May;
14(1):2692.
PMID: 37164975
Mapping tumor metabolic remodeling and their spatial crosstalk with surrounding non-tumor cells can fundamentally improve our understanding of tumor biology, facilitates the designing of advanced therapeutic strategies. Here, we present...
8.
Yang X, Wang A, Li J, Zhou K, Ji K, Ji X, et al.
BMC Cancer
. 2023 Jan;
23(1):53.
PMID: 36647059
Background: The role of preoperative serum tumor markers in HAS patients was vague, we designed the study to explore the effect of preoperative serum tumor markers on predicting the prognosis...
9.
Long J, Chen P, Yang X, Bian J, Yang X, Wang A, et al.
Transl Res
. 2022 Dec;
256:14-29.
PMID: 36586534
Tumor angiogenesis and the immune microenvironment are 2 essential aspects of the tumor microenvironment (TME). The combination of receptor tyrosine kinase (RTK) inhibitor (TKI)-mediated antiangiogenic therapy and CD8 T-lymphocyte-mediated immunotherapy...
10.
Yang X, Wang A
Therap Adv Gastroenterol
. 2022 Dec;
15:17562848221118405.
PMID: 36506751
No abstract available.